Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loading iron(III)porphyrin as the gas/anion binding site into methylated β-cyclodextrin-incorporated polymer hydrogels.

Soft matter·2026
Same author

Intraoperative, interstitial brachytherapy in newly diagnosed brain metastases through cesium-131 collagen tile implant: A multi-institutional case series.

Neuro-oncology advances·2026
Same author

Correction to: Redefining the therapeutic landscape of glioblastomas and brain metastasis through cesium brachytherapy and low-kV intra-operative radiation therapy (IORT).

Journal of neuro-oncology·2026
Same author

Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager.

Molecular therapy. Oncology·2026
Same author

Editorial Expression of Concern: YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.

Oncogene·2026
Same author

miR-181d coordinates homologous recombination and anti-tumor immune responses in glioblastoma.

iScience·2026
Same journal

Long-term Outcomes of Hypo- and Conventional Fractionated Stereotactic Radiotherapy for Non-vestibular Schwannomas: A Retrospective Cohort Study from Ramathibodi Hospital.

Neurologia medico-chirurgica·2026
Same journal

A Coronal Hydrocephalic Index (Eo Index) for Predicting Shunt Responsiveness in Idiopathic Normal Pressure Hydrocephalus.

Neurologia medico-chirurgica·2026
Same journal

Safety and Effectiveness of Embolization via the Ophthalmic Artery with N-butyl Cyanoacrylate for Anterior Skull Base Meningiomas.

Neurologia medico-chirurgica·2026
Same journal

Electroencephalogram-based Objective Assessment of Surgical Expertise during Microvascular Anastomosis Training.

Neurologia medico-chirurgica·2026
Same journal

Time-to-maximum Analysis Using Rapid Processing of Perfusion and Diffusion Software for Assessment of the Risk of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.

Neurologia medico-chirurgica·2026
Same journal

Incidence and Outcomes of Flow Diverter Braid Deformation following Treatment with Non-DFT Wire Devices.

Neurologia medico-chirurgica·2026
See all related articles

Related Experiment Video

Updated: Dec 18, 2025

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

2.8K

Genome Engineering Evolves Brain Tumor Modeling.

Tomoyuki Koga1, Clark C Chen1, Frank B Furnari2

  • 1Department of Neurosurgery, University of Minnesota Medical School.

Neurologia Medico-Chirurgica
|June 16, 2020
PubMed
Summary
This summary is machine-generated.

Genome engineering precisely modifies DNA to create accurate brain tumor models. These models, using human stem cells, mimic patient tumors for better understanding and therapeutic discovery.

Keywords:
CRISPR/Cas9brain tumorgenome engineeringgliomamodeling

More Related Videos

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.8K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.3K

Related Experiment Videos

Last Updated: Dec 18, 2025

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

2.8K
Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

13.8K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.3K

Area of Science:

  • Genomics
  • Cancer Research
  • Neuro-oncology

Background:

  • Programmable nucleases like TALEN and CRISPR-Cas9 enable precise genome engineering.
  • Cancer modeling is crucial for understanding genetic mutations in human cancers.
  • Brain tumors, including glioblastomas, medulloblastomas, and atypical teratoid rhabdoid tumors, present significant clinical challenges.

Purpose of the Study:

  • To develop accurate, genetically engineered brain tumor models using human induced pluripotent stem cells (iPSCs).
  • To investigate the pathobiology and genetic causation of glioblastomas, medulloblastomas, and atypical teratoid rhabdoid tumors.
  • To establish a platform for therapeutic discovery and functional investigation of genetic alterations.

Main Methods:

  • Utilizing TALEN and CRISPR-Cas9 for genome engineering in neural progenitor cells derived from iPSCs.
  • Engrafting engineered cells orthotopically in mice to generate brain tumors.
  • Employing three-dimensional cerebral organoids for studying tumor invasion and therapeutic responses.

Main Results:

  • Engineered iPSC-derived neural progenitor cells formed brain tumors resembling specific molecular subtypes of glioblastoma.
  • These models recapitulated transcriptomic signatures, heterogeneity, chromosomal aberrations, and extrachromosomal DNA amplifications.
  • Genetically engineered models for medulloblastoma and atypical teratoid rhabdoid tumors provided clinically relevant insights.

Conclusions:

  • Genome engineering provides authentic brain tumor avatars driven by patient-derived mutations.
  • These models enhance the understanding of tumorigenesis and facilitate functional genetic studies.
  • The developed models serve as a novel platform for brain tumor research and therapeutic development.